Breast tumor cells with PI3K mutation or HER2 amplification are selectively addicted to Akt signaling.

被引:0
作者
She, Q.-B.
Chandarlapaty, S.
Ye, Q.
Lobo, J.
Haskell, K. M.
Leander, K. R.
DeFeo-Jones, D.
Huber, H. E.
Rosen, N.
机构
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Merck Res Labs, West Point, PA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:222S / 222S
页数:1
相关论文
共 50 条
[41]   THE PI3K/AKT/MTOR SIGNALING IMPAIRS THE SURVIVAL AND PERSISTENCE OF ITNK CELLS IN TUMOR IMMUNOTHERAPY [J].
Liao, Rui ;
Wong, Nathalie ;
Li, Peng ;
Lau, James Y. .
GASTROENTEROLOGY, 2024, 166 (05) :S67-S67
[42]   Neprilysin: A potential regulator of PI3K/AKT signaling in triple negative breast cancer cells [J].
Conway, Rebecca E. ;
Iglesias, Katherine ;
Hired, Zuhaila ;
Rutledge, Grace ;
Kirmani, Khadija .
CANCER RESEARCH, 2019, 79 (13)
[43]   The cytotoxicity of karanjin toward breast cancer cells is involved in the PI3K/Akt signaling pathway [J].
Yu, Jinsong ;
Yang, Han ;
Lv, Chunliu ;
Dai, Xiaowei .
DRUG DEVELOPMENT RESEARCH, 2022, 83 (07) :1673-1682
[44]   DUAL-TARGETING OF AMPK AND PI3K/MTOR IN HER2 OVEREXPRESSING BREAST CANCER [J].
Russillo, Michelangelo ;
Di Cosimo, Serena ;
Serra, Violeta ;
Scaltriti, Maurizio ;
Rodriguez, Olga ;
Cognetti, Francesco ;
Baselga, Jose .
ANNALS OF ONCOLOGY, 2009, 20
[45]   Targeting of PI3K/AKT and MEK Signaling [J].
de Bono, J. S. .
EUROPEAN JOURNAL OF CANCER, 2011, 47 :S84-S84
[46]   PI3K signaling in cancer: beyond AKT [J].
Lien, Evan C. ;
Dibble, Christian C. ;
Toker, Alex .
CURRENT OPINION IN CELL BIOLOGY, 2017, 45 :62-71
[47]   PI3K/AKT signaling and systemic autoimmunity [J].
Patel, RK ;
Mohan, C .
IMMUNOLOGIC RESEARCH, 2005, 31 (01) :47-55
[48]   The PI3K/Akt/mTOR signaling pathway [J].
Dennis, P. A. .
ANNALS OF ONCOLOGY, 2011, 22 :19-19
[49]   PI3K/AKT signaling and systemic autoimmunity [J].
Rahul K. Patel ;
Chandra Mohan .
Immunologic Research, 2005, 31 :47-55
[50]   PI3K/AKT signaling in tumorigenesis and angiogenesis [J].
Jiang, Bing-Hua .
BIOMEDICINE & PHARMACOTHERAPY, 2008, 62 (07) :422-423